The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-Hydroxy-2-oxo-2H-chromene-3-carboxylic Acid (3-p-tolylpropyl)amide ID: ALA4062779
PubChem CID: 137636440
Max Phase: Preclinical
Molecular Formula: C20H19NO4
Molecular Weight: 337.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CCCNC(=O)c2cc3ccc(O)cc3oc2=O)cc1
Standard InChI: InChI=1S/C20H19NO4/c1-13-4-6-14(7-5-13)3-2-10-21-19(23)17-11-15-8-9-16(22)12-18(15)25-20(17)24/h4-9,11-12,22H,2-3,10H2,1H3,(H,21,23)
Standard InChI Key: XMAOASZNRJCMLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
24.1440 -8.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1428 -8.9896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8577 -9.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8559 -7.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5712 -8.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5700 -8.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2869 -9.4070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0096 -8.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0107 -8.1608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2893 -7.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7229 -9.4083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7262 -7.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4396 -8.1642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7282 -6.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1552 -7.7536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8686 -8.1678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5841 -7.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2975 -8.1712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2906 -8.9967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0031 -9.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7196 -9.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7190 -8.1708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0057 -7.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4281 -9.4016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4336 -9.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
2 24 1 0
21 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.38Molecular Weight (Monoisotopic): 337.1314AlogP: 3.17#Rotatable Bonds: 5Polar Surface Area: 79.54Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.69CX Basic pKa: ┄CX LogP: 3.45CX LogD: 3.28Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -0.38
References 1. Endo S, Xia S, Suyama M, Morikawa Y, Oguri H, Hu D, Ao Y, Takahara S, Horino Y, Hayakawa Y, Watanabe Y, Gouda H, Hara A, Kuwata K, Toyooka N, Matsunaga T, Ikari A.. (2017) Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells., 60 (20): [PMID:28976752 ] [10.1021/acs.jmedchem.7b00830 ]